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Abstract
Background: Orthosiphon stamineus (OS) Benth is a medicinal plant and native in Southeast Asia. Pharmacological
effects of OS are attributed to the presence of lipophilic flavones. However; lipophilic compounds suffer from poor
aqueous solubility which limits the OS oral bioavailability and therapeutic applications. Therefore, OS was prepared
in nano formulation form using liposomes from soybean phospholipids. The aim of the present study is to evaluate
the in vitro genotoxicity and in vivo oral toxicity of nano liposomes of OS ethanolic extract (OS-EL).
Methods: In the acute toxicity study Sprague Dawley female rats were given a single dose of the OS-EL at
5000 mg/kg/day orally and screened for two weeks after administration. In the subchronic study, three different doses
of OS-EL were administered for 28 days. Mortality, clinical signs, body weight changes, hematological and biochemical
parameters, gross findings, organ weights, and histological parameters were monitored during the study. Genotoxicity
was assessed using the Ames test with the TA98 and TA100 Salmonella typhimurium strains. High-performance liquid
chromatography was performed for identification and quantification of the major marker compounds in OS-EL. Heavy
metal detection was performed using an atomic absorption spectrometer.
Results: The acute toxicity study showed that the LD50 of the extract was greater than 5000 mg/kg. In the repeated
dose 28-day oral toxicity study, the administration of 250 mg/kg, 500 mg/kg, and 1000 mg/kg/day of OS-EL per body
weight revealed no significant difference in food and water consumptions, bodyweight change, haematological and
biochemical parameters, relative organ weights, gross findings or histopathology compared to the control group. The
Ames test revealed that the OS-EL did not have any potential to induce gene mutations in S. Typhimurium.
Conclusions: Analyses of these results with the information of signs, behaviour, and health monitoring could lead to
the conclusion that the long-term oral administration of OS-EL for 28 days does not cause sub-chronic toxicity.
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Background
Herbs and spices have been used by humans as food
sources and treatment of ailments for generations.
Herbal remedies and herbal products have been used
for over 4000 years for partial treatment ailments and
diseases. Herbal products are usually perceived safe
because of their long-standing use in various cultures.
However, there are case reports of series of adverse
events after administration of herbal products [1].
Unknown effects of some of the medicinal herbs have
been observed for instance allergic reactions, direct
toxic effect especially due to heavy metal poisoning,
adverse effects related to herb desired for pharmaco-
logical action against possible mutagenic effects, drug
contamination and hepatoxycyty effect due to presence
of active agents that can cause acute liver damage [2].
Hence, the first priority in herbal research is assess-
ment of the safety of herbal products. Because of the
absence of strict quality control and the complex mix-
ture of the chemicals present in herbal medicines, there
is limited knowledge available about the chemical com-
positions of these medicines and their effects on human
physiology [3]. This lack of data necessitates the thor-
ough evaluation of the safety of medicinal herbs.
Orthosiphon stamineus (OS) Benth or misai kucing is a
plant from Lamiaceae family. It is a medicinal plant and
native in Southeast Asia. In Malaysia the leaves of this
plant have been used traditionally in urinary lithiasis,
edema, inflammation, eruptive fever, influenza, hepatitis,
jaundice, biliary, rheumatism, diabetes, hypertension di-
uretic and as a remedy for kidney stones and nephritis,
pain in the bladder with frequent urination, as well as
accumulation of uric acid crystals in joints owing to
elevated blood uric acid level [4–6]. Leaves of this plant
are used commonly in Southeast Asian and European
countries as herbal tea, known as “Java tea”. Antioxidant
activity of OS has been investigated by several
researchers [6, 7]. Akowuah et al. [7] showed that flavo-
noids and phenolic acids are implicated on antioxidant
activity of leaves of OS [6]. In a separate study, anti-
angiogenic activity of OS was referred to presence of
high content of antioxidant and phenolic compounds
[8]. The anti-inflammatory and analgesic effects of OS
leaf extract were investigated [9]. In this study, standard-
ized extracts (50 % aqueous methanol) of leaves of OS
were evaluated using animal models for possible anti-
inflammatory and analgesic effects. The results showed
anti-inflammatory activity of OS are contributed to
present of compounds (SEN, EUP and TMF). Pharmaco-
logical effects of OS are attributed to the presence of
polyphenolics, glycosides, lipophilic flavones, caffeic acid
derivatives, triterpenes and diterpens [7–13]. The lipo-
philic flavones of OS including sinensetin (SIN), eupatorin
(EUP) and 3′-hydroxy-5, 6, 7, 4′-tetramethoxyflavone
(TMF) (Fig. 1) have been given considerable attention as
markers of pharmacological activity by several researchers
[14, 15]. However; these lipophilic compounds suffer from
poor aqueous solubility which limits the OS oral
bioavailability and therapeutic applications. Therefore,
O. stamineus has been prepared in nano formulation
form using liposomes from soybean phospholipids [16].
Few scientific data are available to confirm the safety
profile of repeated exposure of OS leaves extracts [17].
However, there is no report on safety study of nano
formulation of O. stamineus leaves extract prepared by
liposomes from soybean phospholipids. Thus, the
present study was designed to evaluate the safety profile
of nano liposomes of O. stamineus ethanolic extract
(OS-EL). Acute and 28-day subchronic oral toxicity
tests were conducted in Sprague Dawley (SD) rats
according to the OECD guidelines, and for the first
time, the genotoxicity of OS-EL was investigated using
Salmonella typhimurium strains. The concentration of
rosmarinic acid (RA), sinensitin (SIN), eupatorin (EUP)
and 3΄-hydroxy-5,6,7,4΄-tetramethoxy flavone (TMF)
present in OS-EL was measured using HPLC. The
detection of heavy metals in OS-EL was conducted
using atomic absorption spectrometry.
Methods
Materials
Nano liposomes of OS ethanolic extract (OS-EL) were
obtained from Department of Pharmaceutical Chemistry,
School of Pharmaceutical Sciences, Universiti Sains
Malaysia (USM). Rosmarininc acid (RA) Sinensitin (SIN),
eupatorin (EUP) and 3΄-hydroxy-5,6,7,4΄-tetramethoxy
flavone (TMF) standards were purchased from Indofine
(New Jersey, USA). HPLC grade nitric acid, methanol and
phosphoric acid were purchased from Merck (Petaling
Jaya, Selangor, Malaysia). Standard lead, cadmium, arsenic
and mercury were purchased from Sigma-Aldrich
(Subang Jaya, Selangor, Malaysia). Deionized water for
HPLC was prepared using Ultra-pure water purifier
system (Elgastat, Bucks, UK).
Instrumentation
The high performance liquid chromatography (HPLC)
was performed using an Agilent Technologies series
1260 infinity (Waldronn, Germany) system equipped
with quaternary pump (G 1311 C), auto sampler (G
1329 B), column oven (G 1316 A) and ultraviolet (UV)
detector (G 1314 F).
High Performance Liquid Chromatography (HPLC)
Preparation of standard compounds and OS-EL sample
Standard compounds For preparation of standard
compounds stock solution, 5 mg of each standard was
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dissolved in 5 mL of methanol and then filtered through
a 0.45 μm filter (Whatman). A series of working stand-
ard solutions were prepared by diluting the above solu-
tion with methanol in the range of 0.01-1000 μg/mL.
OS-EL sample
OS-EL (100 mg) was dissolved in 50 mL of deionized
water and sonicated for 15 min. Working sample solu-
tion of concentration of 2 mg/mL was prepared by dilut-
ing the stock solution with deionized water. The sample
was filtered through a 0.45 μm filter (Whatman).
Chromatographic conditions
The HPLC analysis was performed according to the
method described by Siddiqui and Zhari [15]. The chro-
matographic condition using Nucleosil C18 column
(250 × 4.6 mm internal diameter × 5 μm particles size)
(Macherey Nagel, Germany) was maintained at 25 °C
and the injection sample (20 μL) was eluted with an
isocratic mobile phase comprising of methanol: tetra-
hydrofuran: water (0.1 % H3PO4) mixture in the volume
ratio 55: 5: 40. Flow rate was 0.7 mL/min and detection
was carried out at 330 nm.
Determination of heavy metals
The contents of lead (Pb), cadmium (Cd), arsenic (As)
and mercury (Hg) were determined in OS-EL using
Atomic Absorption Spectroscopy (AAS) Perkin Elmer
model AAnalyst 800, auto sampler, as per standard
method [18]. Briefly, 0.5 g of OS-EL was accurately
weighed and transferred to Teflon vessel. Then 10 mL of
HNO3 was added to the sample vessel. The sample was
diluted to 50 mL with distilled water in plastic dispos-
able tubes and filtered with 2 μm Teflon FilterMate. The
filtered sample was transferred directly to be analyzed by
AAS using nitric acid as blank solution, and standard
lead, cadmium, arsenic and mercury solution made with
2 % nitric acid as reference.
Analysis of antimutagenic effects: ames test
The antimutagenic effects of OS-EL at 500 μg/well were
tested using the Salmonella typhimurium strains TA98
and TA100 for frame-shift and base-pair substitution
mutagenesis, respectively, without (direct effect) meta-
bolic activation. S. typhimurium test strain broth culture
including TA100, TA98, TA1535, and TA1537 are the
most commonly used strains for bacterial mutation assays
within the pharmaceutical industry [19]. 2- Nitrofluorene
(2-NF) and sodium azide phosphate (Chemtron, Singapore)
as direct-acting mutagen for TA98 and TA100, respectively
were used for preparation of positive control. The
broth (Oxoid, Malaysia) and reagents were prepared
according to the method of Maron and Ames [20]. Five
micro litres of incubated TA98 or TA100 cells (16108
cells in 0.1 ml), OS-EL (17.5 ml), and the mutagen
reagent (2.5 ml) were mixed in a 50 mL sterile test tube
with a cap. For preparation of positive control, 100 μL
of 2- Nitrofluorene or sodium azidephosphate were
mixed with 5 μL of incubated TA98 or TA100 cells
(16108 cells in 0.1 ml), diainized water (17.4 mL), and
the mutagen reagent (2.5 ml) in a 50 mL sterile test
tube. The amount of diainized water (17.5 mL) was
mixed by the same amount of mutagen reagent (2.5 ml)
and the incubated TA98 or TA100 cells (5 μL) in a
negative control sample. 200 μL of each mixture was
dispensed into each well of a 96-well sterile plate using
multi-channel pipette. The plates were covered with a
lid and sealed in sterile airtight plastic bag and incu-
bated at 37 °C for three to six days.
Experimental animals
SD rats of either sex (8 weeks of age) were obtained from
the animal house of Universiti Sains Malaysia. The ani-
mals were housed at the Animal Transit Room School
of Pharmaceutical Sciences, Universiti Sains Malaysia
under standard conditions, (temperature, 25 °C; humid-
ity, 51 % ± 10 %). Lighting was artificial at 12 h light
and 12 h dark. Conventional rodent laboratory diet
(Gold Coin Holdings Sdn Bhd) was used with an unlim-
ited supply of drinking water. The study was approved
by the Animal Ethics Committee of Universiti Sains
Malaysia, Penang, Malaysia [Protocol No: USM/Animal
Ethics Approval/2013/ (87) (562) and USM/Animal
Ethics Approval/2013 (87) (563)].
Fig. 1 Chemical structure of (a) rosmarinic acid (b) R1 = OH, R2 = R3 =OCH3, R4 = H, 3ʹ-hydroxy-5,6,7,4ʹ-tetramethoxyflavone, (c) R1 = R2 = R3 = OCH3,
R4 = H, Sinensetin, and (d) R1 = R3 = OH, R2 = OCH3, R4 = H, Eupatorin
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Acute toxicity study in rats
Healthy adult female SD rats (200–225 g) were used in
the acute toxicity study. The study was conducted accord-
ing to the OECD guideline 425 for testing of chemicals by
limit test [21]. On the day of treatment, food but not water
was withheld for overnight, and one group of female rats
(n = 5) was given a single dose of the OS-EL at 5000 mg/
kg/day dissolved in water at a volume of 10 mL/kg by oral
gavage using oral needle. Food was withheld for another
3–4 h after giving the treatment. Animals were observed
individually for signs of possible toxicity at least once
during the first 30 min after dosing, periodically during
the first 24 h and daily thereafter for a total of 14 days. All
observations were systematically recorded with individual
records being maintained for each animal. The rats were
observed visually to identify the followings: changes in
skin and fur, eyes and mucous membranes, and respira-
tory system. Presence of tremors, convulsions, salivation,
diarrhoea, lethargy, sleep and coma was also recorded.
Individual weights of animals were determined shortly
before the test substance was administered and at least
weekly thereafter. Weight changes were calculated and
recorded, and at the end of the test surviving animals
were euthanized and the LD50 values were estimated.
The LD50 is greater than 5000 mg/kg if three or more
animals survive.
Subchronic toxicity study in rats
A subchronic repeated dose (28 days) study in rats was
conducted according to the OECD 407 guideline [22].
SD rats of both sexes were randomly distributed to four
groups of five animals each. The highest dose level
(1000 mg/kg/day) was chosen with the aim of inducing
toxic effects but not death or severe suffering. There-
after, a descending sequence of dose levels was selected
at 2-folded intervals (500 and 250 mg/kg/day) with a
view to demonstrating any dose related response and
no-observed-adverse effects at the lowest dose level
(NOAEL). OS-EL was prepared in water and adminis-
tered orally for 28 days in doses of 250 mg/kg (group I),
500 mg/kg (group II), or 1000 mg/kg (group III). The
control rats (group IV) received only water. All animals
were weighed at start of treatment and at least once a
week. Measurements of food and water consumption
were made weekly. Any signs of toxicity and mortality
were also recorded daily throughout the study period. At
the end of the experiment, all rats were anesthetized by
carbon dioxide inhalation, and blood samples were col-
lected via cardiac puncture into non-heparinized and
EDTA-containing tubes for biochemical and haemato-
logical analyses. After blood collection, the animals were
sacrificed by cervical dislocation, and their organs were
isolated. The brain, heart, liver, spleen, kidneys, adrenal
glands, lungs, stomach, gut, testes (for male), ovaries
and uterus (for female) were excised, weighed using an
analytical lab balance (Mettler-Toledo AX-204, Japan),
and examined macroscopically. Liver, heart, spleen and
kidney were then finally fixed in 10 % buffered neutral
formalin for histopathological examination.
Haematological and biochemical analysis
The following haematological parameters were analyzed
using an automatic haematology analyzer (Sysmex-XT-
1800 Germany): red blood cells (RBCs), white blood cells
(WBCs), packed cell volume (PCV), red cell distribution
width (RDW), prothrombin time and international nor-
malized ratio (PT/I.N.R), activated partial thromboplastin
time (A.P.T.T), reticulocytes, prothrombin time, neutro-
phils, lymphocytes, eosinophils, monocytes, haemoglobin
concentration (Hb), mean corpuscular volume (MCV),
mean corpuscular haemoglobin (MCH), mean corpuscular
haemoglobin concentration (MCHC), and platelet count
(Plt). The following serum biochemical parameters were
measured to investigate major toxic effects in tissues and,
specifically, effects on kidney and liver using a bio-
chemistry autoanalyzer (Olympus 640 Japan): aspartate
aminotransferase (AST), alanine aminotransferase (ALT),
gamma-glutamyl transferase (GGT), creatine, total pro-
tein, globulin, total albumin, albumin/globulin ratio,
phosphorus, calcium, corrected calcium, sodium, potas-
sium, chloride, urea, creatinine, uric acid, alkaline, total
bilirubin, glucose and total Cholesterol.
Histopathological analysis
Histopathological analysis was carried out on the pre-
served organs and tissues. The organs listed above
were harvested and fixed in 10 % buffered neutral
formalin for 48 h and in bovine solution for 6 h. The
fixed organs were processed for paraffin embedding.
Sections (5 mm thick) were cut using a microtome,
processed using an alcoholxylene series, and stained
with haematoxylin and eosin [23].
Statistical analysis
Statistical analysis was carried out using the Statistical
Package for Social Sciences (SPSS 16.0 package). All data
are shown as the mean ± standard error of the mean
(S.E.M) and were analyzed using one-way analysis of
variance (ANOVA). Significant differences between the
control and experimental groups were determined using
LSD multiple comparison test and P value of < 0.05 was
considered significant at P < 0.05.
Results
High Performance Liquid Chromatography (HPLC)
The HPLC method was applied for analyses of RA,
TMF, SIN and EUP in OS-EL. As shown in Fig. 2,
selected standard compounds were well separated by
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the developed HPLC method. Identification of marker
compounds was evaluated by comparing the retention
time and spiking technique. In Table 1, concentration
of standard compounds determined by HPLC in OS-EL
is presented. Results were derived from the mean of
peak area from three replicates injections. The results
show that RA is a major component in OS-EL. Results
from this study are in line with previous reports
suggesting that RA along with other lipophilic flavones
(TMF, SIN and EUP) are the major chemical constitu-
ents in O. stamineus ethanolic extract (OS-E) [24].
Determination of heavy metals
Presence of Cadmium (Cd), mercury (Hg), lead (Pb) and
arsenic (As) was determined in OS-EL by using AAS.
The content of Cd, Pb, As and Pb in OS-EL was found
to be < 0.001, < 0.001, 0.100 ± 0.01 and 0.102 ± 0.01 ppm,
respectively. The acceptable limit for Cd, Pb, As and Hg
according to WHO [25] is 0.3, 10, 5 and 0.5 ppm,
respectively. Therefore, level of these four heavy metals
in OS-EL is within the acceptable range [18].
Bacterial reverse mutation test
The anti-mutagenic potential of OS-EL was screened
using Ames test. In this study, S. typhimurium strains
TA98 and TA100 were used to measure the induction of
frame shift and base-pair mutations, respectively. Bac-
teria histidine (his+) will be independent by mutagens,
and thus, the mutated bacteria can form colonies on
histidine-deficient medium. In this study the mutagens
(sodium azide phosphate and 2-nitrofluorene) were used
as standard direct mutagens on metabolic. Adding
antimutagenic agents considerably reduces the reverse
mutation effects of mutagens. In the plate incorporation
assay, no biologically or statistically significant increase
in the number of revertants was observed with the S.
Typhimurium TA98 or TA100 strain following treatment
with OS-EL at levels of 500 μg/well. On the other hand,
OS-EL at concentrations up to 500 μg per plate did not
increase the number of his + revertant colonies over the
negative control. In general, results show that OS-EL is
Fig. 2 HPLC chromatograms of a: standard compounds and b: OS-EL at 330 nm
Table 1 Quantification of four marker compounds in OS-EL.
Results is shown as average (n = 3)
Compounds Concentration (mg/g)
Rosmarinic acid 219.8 ± 0.6
TMF 11.5 ± 1.0
Sinensetin 23.2 ± 0.1
Eupatorin 166.9 ± 3.5
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not mutagenic in the S. typhimurium mutagenicity assay
(significant at P < 0.05). The results were analyzed
according to the number of positive wells scored in a
96-well micro plate (quoted in Mutachrom Ames test kit
protocol (Table 2).
Acute toxicity study
The acute toxicity study was performed according to
OECD guideline 425, which specifies a limit test dose of
5000 mg/kg. No treatment-related mortality was observed
at 5000 mg/kg, and throughout the 14-day observation
period, there were no significant changes in behaviour,
such as apathy, hyperactivity, or morbidity, in any of the
animals. No abnormal changes in body weight, respiration
rate, or heart rate attributable to the treatment were
noted. Han et al. [17] in 2008 reported that no overt signs
of acute toxicity or death were observed in female rats
and LD50 for O. stamineus methanolic extract was
shown to be higher than 5000 mg/kg. In the present
study, OS-EL was found to be safe at a dose of
5000 mg/kg, and therefore, the LD50 value for oral
toxicity was considered to be greater than 5000 mg/kg.
Subchronic toxicity study
Effects of 28 days of oral administration of OS-EL on
general behaviour and haematological and biochemical
parameters in rats were studied. Administration of OS-EL
at doses of 250, 500 and 1000 mg/kg orally every 24 h for
28 days did not show any mortality in the tested animals.
During the entire experimental period no signs of ob-
servable toxicity were detected. Body weight for normal
young male and female SD rats in treatment groups
was not significantly changed as compared to the nega-
tive control group (Fig. 3). In both male and female SD
rats no significant changes in the external physical
structure of the organs, their relative organ weight,
food and water consumption between the treated
groups of rats and the control group was observed
(data not shown). The effects of subchronic treatment
on the haematological parameters are presented in
Table 3. None of the parameters except the lympho-
cytes and monocytes in female rats treated with 250
and 500 mg/kg OS-EL, respectively showed a signifi-
cant difference with respect to the untreated group.
The changes in lymphocytes and monocytes were not
dose dependent because they were only observed in the
group treated with 250 and 500 mg/kg, not in the
group treated with the higher dose. In general, all
tested haematological parameters, including haemoglo-
bin, red blood cells, white blood cells, packed cell volume,
red cell distribution width, prothrombin time and inter-
national normalized ratio, activated partial thromboplastin
time, reticulocytes, prothrombin time, neutrophils, lym-
phocytes, eosinophils, monocytes, mean corpuscular vol-
ume, mean corpuscular haemoglobin, mean corpuscular
haemoglobin concentration, and platelet count were
within the normal range. The biochemical profiles of the
treated and control groups are shown in Table 4. The oral
administration of OS-EL for up to 28 days did not cause
significant dose dependent changes in sodium, potas-
sium, urea, creatinine, uric acid, calcium, corrected
calcium, phosphate, total protein, albumin, globulin,
albumin/ globulin ratio, alkaline, total bilirubin, GGT,
AST, ALT, glucose and total cholesterol in both male
and female rats. However, a dose-dependent increase
in the level of chloride was observed in female rats.
In general, administration of OS-EL at dose of 250,
500 and 1000 mg/kg did not cause any abnormal
changes as reflected by the liver and renal function
tests after 28 days treatment.
Effects of 28 days of oral treatment with OS-EL on
histopathological parameters in rats
The results of the histopathological studies provided
evidence supporting the findings of the biochemical
analysis. Histopathological sections of heart, liver, spleen
and kidneys are shown in Figs. 4 and 5. No lesions,
inflammation or pathological changes related to treat-
ment with OS-EL were observed in the organs of the
animals from the treatment groups compared to the un-
treated group. In general, the treatment-related results
were very similar to those of the control group.
Effects of 28 days of oral treatment with OS-EL on the
organ weights of the rats
The weights of the organs for control and treated rats
are shown in Table 5. There were no significant differ-
ences in the organ weights between the treated groups
and the control group.
Discussion
The first priority in herbal research is assessment of the
safety of herbal products. Thus, to determine the toxic
characteristics of a natural product extract, systematic
toxicological studies must be performed using various
experimental models to predict the toxicity and set
criteria for selecting a safe dose in humans. Toxicity
effect of drug in animals and humans ascertain in the
Table 2 The number of positive wells scored in a 96-well
microplate leading to clear significance in the fluctuation test
Number of wells positive
in negative control plate
Number of wells positive in treatment plate
0.05 0.01 0.001
0 3 6 10
1 5 8 12
2 7 10 14
3 9 12 16
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form of adverse haematological, gastrointestinal or car-
diovascular effects, structural rearrangements caused
by different types of DNA damage. Therefore, for
evaluation the overall toxicity of plant extract, deter-
mining of the adverse effects of single and repeated
dosing in experimental animals and the mutagenicity
using mutant strains of bacteria may be more relevant.
Since few scientific studies have been carried out to
determine the safety of traditional medicinal herbs, few
scientific data are available to confirm the safety profile
of repeated exposure of OS leaves extracts [17]. How-
ever, there is no safety study undertaken to evaluate
and focus on the acute and chronic toxicity nano
formulation of OS leaves extract prepared by liposomes
from soybean phospholipids. Thus, the present study was
designed to evaluate the oral toxicity of nano liposomes of
OS ethanolic extract (OS-EL) and its genotoxicity in
rodents and mutant strains of S. Typhimurium.
Toxicity of plant extract may not be attributed to
inherent toxicity of plant constituents or ingredients.
However, it may be because of manufacturing malprac-
tice and contamination [1]. Heavy metals test is essential
to ensure safety of the plant material. Contamination of
plant material with harmful heavy metals is limited to
low levels. The primary source of this contamination,
beside ground water, is milling operations. In this study
we measured the content of harmful heavy metals (cad-
mium, mercury, lead and arsenic) in OS-EL by AAS.
Fig. 3 Body weight changes of female (a) and male (b) Sprague Dawley rats during the 28-day toxicological assessment. The vehicle, water
(10 ml/kg/day), was administered to rats in the control group. No significant differences were detected between the treated (250, 500 and 1000 mg/kg)
and control (vehicle 10 ml/kg) groups. All values are expressed as the mean ± S.E.M. (n= 5)
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The level of these four heavy metals in OS-EL was well
within the acceptable range [18].
Determination of LD50 is an initial step to be con-
ducted during evaluation of the toxic effect of medicinal
plants. LD50 value is an estimation of the potency of
toxicant or agents to subjects which causes fifty percent
of lethality and is normally expressed in mg/kg body
weight [26]. Data from the acute toxicity study help us
to determine LD50 values that provide many indices of
potential types of drug activity [27]. In the acute toxicity
assay, oral treatment with OS-EL was well tolerated. A
dose of 5000 mg/kg OS-EL administered to female rats
did not cause signs of toxicity, changes in behaviour, or
mortality up to 14 days of observation and LD50 value
was shown to be greater than 5000 mg/kg. In principle,
the limit test method is not intended for determining an
Table 3 Effects of the subchronic oral administration of OS-EL on hematological parameters in Sprague Dawley rats
Control water OS-EL (mg/kg) 250 500 1000
Female rats
Haemoglobin g/L 141 ± 2.64 148.66 ± 3.14 147.6 ± 3.74 143.5 ± 2.84
RBC 1012 7.68 ± 0.21 8.03 ± 0.09 7.82 ± 0.26 7.54 ± 0.13
PCV L/L 0.44 ± 0.01 0.48 ± 0.01 0.45 ± 0.01 0.46 ± 0.00
MCV f/L 58 ± 0.70 60 ± 1.94 58.8 ± 3.15 62 ± 0.96
MCH Pg 18.2 ± 0.2 18.66 ± 0.51 18.8 ± 0.66 19.25 ± 0.42
MCHC g/L 317 ± 3.88 308.66 ± 2.06 323.6 ± 6.91 307 ± 6.16
RDW % 13.01 ± 3.24 15.16 ± 0.88 16.5 ± 1.30 14.27 ± 0.25
White cell count 109/L 8.78 ± 1.14 6.36 ± 0.88 5.74 ± 0.69 7.17 ± 0.33
Neutrophils 109/L 1.82 ± 0.31 2.06 ± 0.18 2.02 ± 0.58 1.97 ± 0.36
Lymphocytes 109/L 6.66 ± 0.85 3.83 ± 0.60* 3.5 ± 0.18 4.55 ± 0.18
Monocytes 109/L 0.14 ± 0.07 0.36 ± 0.06 0.2 ± 0.05* 0.425 ± 0.04
Eosinophils 109/L 0.18 ± 0.02 0.06 ± 0.02 0.05 ± 0.02 0.15 ± 0.02
Platelets 109/L 543.4 ± 93.91 657.66 ± 56.86 520 ± 40.72 573.75 ± 84.71
Reticulocytes 109/L 225.5 ± 9.28 270.33 ± 54.17 283.4 ± 16.28 222.5 ± 10.26
Prothrombin time Seconds 15.32 ± 0.38 15.5 ± 0.00 15.6 ± 0.27 15.55 ± 0.36
I.N.R 1.3 ± 0.03 1.28 ± 0.03 1.23 ± 0.02 1.3 ± 0.03
A.P.T.T Seconds 42.07 ± 2.10 49.9 ± 1.52 41.9 ± 2.73 42.07 ± 2.10
Male rats
Haemoglobin g/L 149.6 ± 2.82 152.75 ± 2.69 158 ± 3.97 158 ± 2.12
RBC 1012 8.80 ± 0.24 8.74 ± 0.10 8.94 ± 0.22 8.99 ± 0.07
PCV L/L 0.46 ± 0.00 0.47 ± 0.01 0.47 ± 0.01 0.46 ± 0.00
MCV f/L 52.8 ± 1.01 53.75 ± 0.92 52.66 ± 1.43 52 ± 0.44
MCH Pg 17 ± 0.31 17.5 ± 0.25 17.66 ± 0.25 17.6 ± 0.24
MCHC g/L 322.2 ± 2.57 325 ± 9.59 335.66 ± 5.59 337.6 ± 3.66
RDW % 16.7 ± 0.74 16.45 ± 0.51 16.33 ± 0.18 16.32 ± 0.45
White cell count 109/L 10.88 ± 1.29 9.77 ± 3.11 8 ± 1.42 7.34 ± 1.12
Neutrophils 109/L 4.88 ± 0.76 4.45 ± 2.16 4.03 ± 1.02 2.94 ± 0.42
Lymphocytes 109/L 5.28 ± 0.44 4.7 ± 0.99 3.53 ± 0.40 3.8 ± 0.66
Monocytes 109/L 0.44 ± 0.11 0.4 ± 0.14 0.2 ± 0.07 0.48 ± 0.07
Eosinophils 109/L 0.23 ± 0.02 0.2 ± 0.01 0.16 ± 0.05 0.17 ± 0.06
Platelets 109/L 559 ± 20.04 488.25 ± 41.98 484 ± 73.94 487.8 ± 54.36
Reticulocytes 109/L 267.8 ± 17.19 320.25 ± 15.57 252 ± 28.25 224.6 ± 11.33
Prothrombin time Seconds 16.67 ± 0.49 15.57 ± 0.31 16.65 ± 0.34 17.44 ± 0.21
I.N.R 1.37 ± 0.06 1.25 ± 0.04 1.35 ± 0.03 1.46 ± 0.02
A.P.T.T Seconds 43.46 ± 1.76 42.17 ± 3.90 46.85 ± 2.30 50.32 ± 3.42
The results are shown as average ± S.E.M (n = 5), (*P < 0.05)
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Table 4 Effects of the subchronic oral administration of OS-EL on biochemical parameters in Sprague Dawley rats
Control water OS-EL (mg/kg) 250 500 1000
Female rats
Sodium mmol/L 138.2 ± 0.96 139.5 ± 0.25 140.2 ± 0.8 139.5 ± 1.06
Potassium mmol/L 10.34 ± 0.52 5.9 ± 0.16* 6.75 ± 0.74* 7.55 ± 0.79
Chloride mmol/L 95.6 ± 1.02 99.25 ± 0.56 100.6 ± 0.67* 100.75 ± 1.76*
Urea mmol/L 9.14 ± 0.32 10.57 ± 0.48 10.06 ± 0.37 10.77 ± 0.40
Creatinine mmol/L 48.6 ± 3.94 34 ± 1.93 34.6 ± 4.81 35 ± 2.25
Uric Acid mmol/L 0.154 ± 0.02 0.19 ± 0.03 0.176 ± 0.02 0.20 ± 0.02
Calcium mmol/L 2.87 ± 0.04 2.91 ± 0.08 2.88 ± 0.05 2.86 ± 0.03
Corrected Calcium mmol/L 2.97 ± 0.02 3.03 ± 0.08 3.00 ± 0.05 2.98 ± 0.02
Phosphate mmol/L 3.05 ± 0.07 2.56 ± 0.16 3.56 ± 0.35 2.93 ± 0.12
Total Protein g/L 85.4 ± 1.20 81 ± 1.15 81 ± 1.87 79.75 ± 1.05
Albumin g/L 36 ± 0.83 34 ± 0.63 33.8 ± 2.31 33.75 ± 0.99
Globulin g/L 49.4 ± 0.4 47 ± 1.31 47.2 ± 2.81 46 ± 1.15
Albumin/ Globulin ratio g/L 0.72 ± 0.02 0.72 ± 0.02 0.73 ± 0.09 0.73 ± 0.03
Alkaline U/L 217.2 ± 33.77 183 ± 14.60 231.6 ± 36.04 264 ± 29.41
Total Bilirubin umol/L <2 <2 <2 <2
GGT U/L <3 <3 <3 <3
AST U/L 398.4 ± 92.12 202 ± 29.52 256.6 ± 37.62 230.25 ± 48.13
ALT U/L 82.4 ± 9.04 63.5 ± 5.48 72.2 ± 7.76 62 ± 3.40
Glucose mmol/L 6.18 ± 0.27 5.87 ± 0.23 6.12 ± 1.41 7.15 ± 0.75
Total Cholesterol mmol/L 2.5 ± 0.33 2.25 ± 0.05 2.24 ± 0.14 2.5 ± 0.09
Male rats
Sodium mmol/L 139 ± 0.54 141.25 ± 0.92 138.2 ± 1.74 142.8 ± 1.01
Potassium mmol/L 6.06 ± 0.45 4.72 ± 0.30 6.5 ± 0.00 6.12 ± 0.05
Chloride mmol/L 101.75 ± 0.67 97.75 ± 0.42* 101.2 ± 0.66 101.4 ± 0.6
Urea mmol/L 8.75 ± 0.43 7.27 ± 0.18 8.5 ± 0.29 9.66 ± 0.62
Creatinine mmol/L 34 ± 0.89 29.25 ± 2.64 46.6 ± 2.29* 37.8 ± 2.70
Uric Acid mmol/L 0.14 ± 0.02 0.12 ± 0.01 0.23 ± 0.03 0.12 ± 0.00
Calcium mmol/L 2.48 ± 0.06 2.92 ± 0.02* 2.50 ± 0.06 2.57 ± 0.02
Corrected Calcium mmol/L 2.62 ± 0.06 3.10 ± 0.03* 2.58 ± 0.07 2.68 ± 0.01
Phosphate mmol/L 2.93 ± 0.09 2.95 ± 0.10 3.30 ± 0.33 2.81 ± 0.14
Total Protein g/L 69.5 ± 0.85 75 ± 0.81 71.2 ± 0.96 71.6 ± 0.97
Albumin g/L 34 ± 0.83 30.75 ± 0.42* 36 ± 0.54 34.6 ± 0.50
Globulin g/L 36 ± 0.36 44.25 ± 1.11* 35.2 ± 0.58 37 ± 1.22
Albumin/ Globulin ratio g/L 0.93 ± 0.02 0.69 ± 0.02* 1.02 ± 0.01 0.94 ± 0.04
Alkaline U/L 200.6 ± 23.26 340.75 ± 4.41* 175.6 ± 16.35 188.2 ± 12.03
Total Bilirubin umol/L <2 <2 <2 <2
GGT U/L <3 <3 <3 <3
AST U/L 264.25 ± 47.71 167.5 ± 21.26 234.75 ± 34.91 225.6 ± 34.90
ALT U/L 83.4 ± 13.64 88.25 ± 9.53 102.25 ± 27.27 83.2 ± 17.14
Glucose mmol/L 3.86 ± 0.11 6.57 ± 0.27* 3.7 ± 0.14 3.7 ± 0.36
Total Cholesterol mmol/L 1.56 ± 0.05 2.25 ± 0.11* 1.8 ± 0.07 1.78 ± 0.07
The results are shown as average ± S.E.M (n = 5), (*P < 0.05)
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exact LD50 value, but it serves as a suggestion for classi-
fying the plant extract based on the expectation at which
dose level the animals are expected to survive [28].
According to the chemical labelling and classification of
acute systemic toxicity recommended by OECD, OS-EL
was assigned class 5 status (LD 50 > 5000 mg/kg), which
was the lowest toxicity class. Any substance with an
LD50 between 5000 and 15,000 mg/kg is considered
nontoxic [29]. Since no toxic effects were found during
the acute toxicity study, further investigation was
conducted to evaluate the subchronic toxicity of OS-EL
up to 28 days in rats to prepare the comprehensive toxi-
cology data of this medicinal plant.
Subchronic studies provides some indication of
continuous or repeated exposure of plant extracts or
compounds over a portion of the average life span of
experimental animals, such as rodents. Specifically,
they provide information on target organ toxicity and
also help to determine appropriate dose regimens for
longer term studies [30]. The results of the subchronic
(28-day) toxicity study of OS-EL demonstrated no clin-
ical signs for toxicity, mortality or change in the normal
behaviour in either sex. In addition, the treated rats did
not show any significant alteration in water or food
consumption (data not shown). Significant reduction in
food and water intake is suggested as being responsible
for the observed decrement in body weight gain. In the
OS-EL-treated animals, the body weight gain was not
significantly different from that of the control group,
suggesting that OS-EL did not alter food intake
through appetite suppression [31]. The body weight
changes serve as a sensitive indication of the general
health status of animals [32]. The relative organs
weights have been observed in toxicity studies to be a
relatively sensitive indicator for particular organs, and,
thereafter, define toxicity as significant changes ob-
served in those particular organs [33]. The results of
this study revealed that the weights of the organs did
not significantly differ from those of the control group.
Since there was no reduction in body and relative
organs weights of the treated animals at any of the
doses tested, we concluded OS-EL is safe even at the
highest studied dose (1000 mg/kg) and it is non-toxic
to these organs, after 28 days of exposure.
The serum haematology and clinical biochemistry
analyses were done to evaluate the possible alterations in
liver and renal functions influenced by OS-EL. Results
showed Significant differences (P < 0.05) in lymphocytes
and monocytes level in female rats treated with 250 and
500 mg/kg OS-EL, respectively with respect to the
Fig. 4 Representative microscopic findings for the heart, kidneys, liver and spleen of female Sprague Dawley rats treated orally with 250, 500 and
1000 mg/kg OS-EL or the control (water) for 28 days
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untreated group. The changes in lymphocytes and
monocytes were not dose dependent because they were
only observed in the group treated with 250 and
500 mg/kg, not in the group treated with the higher
dose. Because no corresponding changes were observed
in the other parameters, the significant changes in lym-
phocytes and monocytes are not related to treatment
with OS-EL [34]. Almost all biochemical parameters an-
alyzed remained within the reference levels for the spe-
cies [34]. However, a dose-dependent increase in the
level of chloride was observed in female rats. This in-
crease could be related to dehydration [35]. When the
plasma membranes of liver cells are damaged, a variety
of enzymes located in the cytosol are released into the
blood stream. The levels of these enzymes in the serum
are quantitative measures of the extent and type of he-
patocellular damage. In male rats treated with 250 mg/
kg of OS-EL the level of chloride, globulin, alkaline, cal-
cium, glucose and chlosterol and in the male rats treated
with 500 mg/kg of OS-EL the level of createninn
showed significant increscent (P < 0.05) with respect
to the untreated group. The increase in the level of
globulin and alkaline could be related to mild liver cell
damage. The increase in the level of createnin in the rats
treated with 500 mg/kg may be because of dehydration or
kidney damage. However, these changes are not dose de-
pendant, because there were not observed in the rats
treated with higher dose, therefore these changes are not
related to treatment with OS-EL. The lack of alteration in
the liver parameters (alkaline phosphatase, aspartate trans-
aminase, alanine transaminase, creatine phosphokinase,
total protein, albumin/globulin ratio, and bilirubin) and
indicators of kidney function (creatinine, uric acid, phos-
phorus, calcium, sodium and potassium) shows that the
administration of OS-EL for 28 days at dose of 250, 500
and 1000 mg/kg did not cause any abnormal changes as
reflected by the liver and renal function tests.
These results could be confirmed by histopathological
examination of selected organs (heart, liver, spleen, and
kidneys) harvested from treated and control animals.
This analysis revealed normal architecture for all vital
organs. The microscopic examination revealed that none
of the organs from the treated rats showed any alteration
in cell structure, inflammation or any unfavourable
effects when viewed under the light microscope using
multiple magnification powers. Generally, any damage to
the parenchymal liver or kidney cells results in eleva-
tions of both transaminases in the blood [36]. Since
there are no significant increases observed in liver and
kidney parameters, therefore strongly suggest that there
Fig. 5 Representative microscopic findings for the heart, kidneys, liver and spleen of male Sprague Dawley rats treated orally with 250,
500 and 1000 mg/kg OS-EL or the control (water) for 28 days
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are no obvious detrimental effects or morphological
disturbances caused by the daily oral administration of
OS-EL for 28 days, even at the highest tested dose of
1000 mg/kg.
The results from the genotoxicity assay show that, even
at a very high concentration (5000 mg per plate), OS-EL
did not increase the number of histidine revertant
colonies over the negative control in the tester strains
TA100 and TA98. Because the standard mutagens used in
this study (sodium azide phosphate and 2-nitrofluorene)
induced a clear positive response, the above results
indicate that OS-EL was not mutagenic in this assay.
The absence of mutagenicity for OS-EL in the tested
S. typhimurium strains indicates that OS-EL does not
affect the structural integrity of DNA.
The HPLC analysis shows that OS-EL contained
remarkably high levels of lipophilic flavones of including
sinensetin (SIN), eupatorin (EUP) and 3′-hydroxy-5, 6,
7, 4′-tetramethoxyflavone (TMF) and phenolic including
rosmarinic acid (RA). These compounds are known to
Table 5 Effects of the subchronic oral administration of OS-EL on organ weights in Sprague Dawley rats
Organ weight (g) Control water OS-EL (mg/kg) 250 500 1000
Female rats
Liver 7.95 ± 0.35 7.36 ± 0.38 8.06 ± 0.56 8.75 ± 0.39
Right kidney 0.66 ± 0.07 0.69 ± 0.06 0.75 ± 0.03 0.73 ± 0.03
Left kidney 0.69 ± 0.05 0.66 ± 0.03 0.72 ± 0.03 0.68 ± 0.02
Right ovarie 0.09 ± 0.02 0.07 ± 0.00 0.07 ± 0.00 0.06 ± 0.00
Left ovarie 0.08 ± 0.01 0.0625 ± 0.00 0.06 ± 0.00 0.06 ± 0.01
Uterus 0.45 ± 0.04 0.52 ± 0.04 0.49 ± 0.04 0.54 ± 0.04
Brain 1.71 ± 0.00 1.75 ± 0.03 1.69 ± 0.05 1.54 ± 0.13
Spleen 0.61 ± 0.04 0.52 ± 0.03 0.65 ± 0.09 0.59 ± 0.01
Lung 1.60 ± 0.09 1.28 ± 0.06 1.46 ± 0.149 1.36 ± 0.08
Right adrenal gland 0.06 ± 0.00 0.05 ± 0.00 0.05 ± 0.00 0.05 ± 0.00
Left adrenal gland 0.06 ± 0.01 0.05 ± 0.00 0.04 ± 0.00 0.05 ± 0.00
Full stomach 6.47 ± 0.36 6.78 ± 0.89 7.66 ± 1.03 7.73 ± 0.42
Empty stomach 1.38 ± 0.05 1.18 ± 0.08 1.245 ± 0.09 1.41 ± 0.05
Gut 11.62 ± 0.68 11.47 ± 0.37 12.3 ± 0.56 11.1 ± 0.44
Empty gut 7.37 ± 0.36 6.47 ± 0.42 7.29 ± 0.25 7.74 ± 0.16
Thymus 0.26 ± 0.04 0.23 ± 0.00 0.29 ± 0.02 0.28 ± 0.04
Heart 0.83 ± 0.04 0.84 ± 0.03 0.76 ± 0.05 0.75 ± 0.03
Male rats
Liver 7.44 ± 0.13 8.58 ± 0.49 8.51 ± 0.48 8.00 ± 0.19
Right kidney 0.88 ± 0.03 1.13 ± 0.04 1.02 ± 0.05 0.96 ± 0.05
Left kidney 0.87 ± 0.02 0.92 ± 0.02 0.89 ± 0.03 0.95 ± 0.03
Right testes 1.32 ± 0.04 1.26 ± 0.02 1.33 ± 0.04 1.34 ± 0.04
Left testes 1.29 ± 0.05 1.26 ± 0.03 1.29 ± 0.05 1.38 ± 0.05
Brain 1.81 ± 0.03 1.86 ± 0.05 1.86 ± 0.10 1.83 ± 0.01
Spleen 0.53 ± 0.03 0.71 ± 0.01 0.65 ± 0.07 0.614 ± 0.04
Lung 1.58 ± 0.09 1.58 ± 0.04 1.57 ± 0.10 1.38 ± 0.05
Right adrenal gland 0.05 ± 0.00 0.06 ± 0.01 0.03 ± 0.00 0.04 ± 0.00
Left adrenal gland 0.04 ± 0.00 0.04 ± 0.00 0.04 ± 0.00 0.04 ± 0.00
Full stomach 2.43 ± 0.29 2.78 ± 0.34 2.83 ± 0.23 2.6 ± 0.36
Empty stomach 1.22 ± 0.04 1.30 ± 0.03 1.35 ± 0.08 1.31 ± 0.03
Gut 12.1 ± 0.36 11.97 ± 0.60 12 ± 0.36 12.14 ± 0.41
Empty gut 7.44 ± 1.65 6.8 ± 0.50 6.16 ± 0.32 7.00 ± 0.66
Thymus 0.24 ± 0.03 0.37 ± 0.02 0.35 ± 0.07 0.30 ± 0.04
Heart 0.84 ± 0.06 0.91 ± 0.00 0.88 ± 0.07 0.79 ± 0.01
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be a rich source of biologically active antioxidants [7] and
have received much attention recently because of their
diverse pharmacological properties. Studies conducted to
elucidate the mechanisms of protection against mutagens
have found that the presence of phenolic and flavonoid
compounds can suppress the toxicity and genotoxicity of
toxins because phenolic and flavonoid compounds can
readily scavenge free radicals or activate antioxidant
enzyme cascades [3].
Conclusion
In light of these findings, we may conclude that acute and
subchronic (28 day) oral administration of OS-EL is safe at
the doses (250, 500 and 1000 mg/kg body weight/day in SD
rats) tested in this study. In summary, the administration of
OS-EL for 28 days did not cause death or visible signs of
toxicity on the nervous system, respiratory system, or
other physiological functions in any animals of both
sexes. Furthermore, OS-EL did not have mutagenic
effects even at extremely high concentrations in S. typhi-
murium strains. The HPLC analysis of OS-EL reveals that
RA, TMF, SIN and EUP were present at high levels. The
heavy metal analysis of OS-EL shows the absence of toxic
levels of heavy metals. Cumulatively, these findings
suggest that nano formulation of O. stamineus ethanolic
extract (OS-EL) prepared by liposomes from soybean
phospholipids can be considered devoid of acute and sub-
chronic toxicity and genotoxicity. These data suggest that
the consumption of OS-EL poses no threat of potential
health risks. Further studies to determine the effects of
OS-EL on animal foetus, pregnant animals, and their
reproductive capacity are needed to complete the safety
profile of this herb.
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